PolyPid Ltd PYPD
Annual
Quarterly
No annual revenue total was found in PolyPid Ltd's SEC filings.
PolyPid Ltd (PYPD) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. Free cash flow was -$28.1 million. As of Dec 31, 2025 it held $6.4 million in cash and investments and $2.8 million in total debt.
Revenue
—
Net income
$-34.17M
-17.7% vs prior year
Operating cash flow
$-27.88M
-26.9% vs prior year
Free cash flow
$-28.09M
-27.5% vs prior year
EPS
$2.09
-57.4% vs prior year
Dividend per share
None
Shares outstanding
18.20M
+78.6% vs prior year
Net cash
$3.61M
FY 2025
Operating margin
—
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- PYPD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Petach Tikva, Israel
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1611842
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Operating income | -$33.0M | -$28.0M | -$22.9M | -$38.9M | -$43.1M |
| Net income | -$34.2M | -$29.0M | -$23.9M | -$39.6M | -$42.6M |
| Diluted EPS | $2.09 | $4.91 | $16.93 | $61.09 | $68.27 |
| Operating cash flow | -$27.9M | -$22.0M | -$17.2M | -$34.3M | -$32.4M |
| Free cash flow | -$28.1M | -$22.0M | -$17.4M | -$36.1M | -$35.0M |
| Total assets | $22.3M | $25.2M | $15.4M | $26.0M | $44.2M |
| Stockholders' equity | $11.0M | $7.7M | -$2.1M | $5.8M | $36.0M |
| Cash and investments | $6.4M | $15.6M | $14.6M | $20.3M | $19.2M |
| Total debt | $2.8M | $9.6M | $5.4M | $7.6M | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Oct 28, 2026 | Oct 28, 2026 |
| 6-K | Current report (foreign issuer) | Oct 1, 2026 | Oct 1, 2026 |
| 6-K | Current report (foreign issuer) | Oct 1, 2026 | Oct 1, 2026 |
| 6-K | Current report (foreign issuer) | Aug 12, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | Aug 12, 2026 | Aug 12, 2026 |
| 6-K | Current report (foreign issuer) | Jul 29, 2026 | Jul 29, 2026 |
All 254 PolyPid Ltd SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.